Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/MERCK-CO-INC-13611/news/Vaccinex-Reports-Phase-Ib-KEYNOTE-B84-Combination-Study-of-Keytruda-and-Pepinemab-in-Patients-with-37460571/?utm_source=whatsapp&utm_medium=social&utm_campaign=share